CKH Food & Health Limited - Asset Resilience Ratio
CKH Food & Health Limited (900120) has an Asset Resilience Ratio of 40.41% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 900120 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how CKH Food & Health Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is CKH Food & Health Limited's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down CKH Food & Health Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CKH Food & Health Limited (900120) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩1.03 Billion | 40.41% |
| Short-term Investments | ₩0.00 | 0% |
| Total Liquid Assets | ₩1.03 Billion | 40.41% |
Asset Resilience Insights
- Very High Liquidity: CKH Food & Health Limited maintains exceptional liquid asset reserves at 40.41% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
CKH Food & Health Limited Industry Peers by Asset Resilience Ratio
Compare CKH Food & Health Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for CKH Food & Health Limited (2016–2023)
The table below shows the annual Asset Resilience Ratio data for CKH Food & Health Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 22.74% | ₩522.47 Million ≈ $354.07K |
₩2.30 Billion ≈ $1.56 Million |
+7.39pp |
| 2022-06-30 | 15.35% | ₩340.71 Million ≈ $230.89K |
₩2.22 Billion ≈ $1.50 Million |
+8.64pp |
| 2021-06-30 | 6.70% | ₩147.58 Million ≈ $100.01K |
₩2.20 Billion ≈ $1.49 Million |
-52.55pp |
| 2020-06-30 | 59.26% | ₩1.26 Billion ≈ $856.20K |
₩2.13 Billion ≈ $1.44 Million |
-11.39pp |
| 2017-06-30 | 70.65% | ₩2.55 Billion ≈ $1.73 Million |
₩3.61 Billion ≈ $2.45 Million |
+9.79pp |
| 2016-06-30 | 60.86% | ₩2.22 Billion ≈ $1.50 Million |
₩3.64 Billion ≈ $2.47 Million |
-- |
About CKH Food & Health Limited
CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 a… Read more